An interventional study of endometrial biopsy in Genomic Human Endometrial Expression Profile, sponsored by Instituto Valenciano de Infertilidad, IVI VALENCIA. Completed at 1 site in Spain. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-02-15.
Sponsored by Instituto Valenciano de Infertilidad, IVI VALENCIA · Not applicable, Interventional, and Basic science
The aim of this study is to analyse genomics profile expression in endometrium under different endometrial priming for recipients.
We analyze the genomic profile of egg donors in different endometrial priming protocols, compared with natural cycle, including the conventional single long acting GnRH agonist injection in the mid luteal phase of the previous cycle of the endometrial priming and the single daily antagonist injection (Cetrorelix 0.25 mg) administered in the early follicular phase followed by endometrial priming. Endometrial biopsy will be taken in luteinizing hormone
Instituto Valenciano de Infertilidad, IVI VALENCIA is the lead sponsor of 70 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Natural cycle endometrial biopsy, lh+7
Procedure: endometrial biopsy
Antagonist cycle + endometrial priming for egg donation program. endometrial biopsy, p4+5
Procedure: endometrial biopsy
Agonist cycle + endometrial priming for egg donation program endometrial biopsy, p4+5
Procedure: endometrial biopsy
endometrial biopsy
genetic endometrial human profile expression
implantation related genes profile expression
Time frame: Oocyte donors will be followed up for four to six months
This study is completed, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto Valenciano de Infertilidad, IVI VALENCIA